Atlas Trials

IrsiCaixa

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch IrsiCaixa

RecordFirmDate
A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals (NCT05208125)IrsiCaixa2022-03-30
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation (NCT04720742)IrsiCaixa2021-02-28
Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer (NCT03767465)IrsiCaixa2018-10-26
LoViReT (Low Viral Reservoir Treated Patients) (NCT02972931)IrsiCaixa2018-01-18

Track IrsiCaixa automatically

Every clearance here is in the API, with alerts when new ones post.